Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cedric Hermans

Showing results (51-60 of 222) with videos related to

Pageof 23
Sort By:
Blood Advances|July 1, 2020
First report of emicizumab use in a female patient with severe hemophilia AGéraldine Verstraete, Catherine Lambert, Cedric Hermans
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 22, 2021
Recombinant FVIIa in elective non-orthopaedic surgery of adults with haemophilia and inhibitors: A systematic literature reviewGerard Dolan, Jan Astermark, Cedric Hermans
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 16, 2022
Emicizumab dose capping in obese patients with Haemophilia A: Early outcomes at a single centreEvelien Krumb, Catherine Lambert, Cedric Hermans
Thrombosis and Haemostasis|March 9, 2012
Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiencyCedric Hermans, Stéphane Eeckhoudt, Catherine Lambert
Haematologica|May 7, 2013
Impact of being underweight or overweight on factor VIII dosing in hemophilia A patientsSéverine Henrard, Niko Speybroeck, Cedric Hermans
Clinical Toxicology (Philadelphia, Pa.)|March 18, 2008
Kinetics and determinants of the changes of CC16, a lung secretory protein in a rat model of toxic lung injuryPhilippe Hantson, Alfred Bernard, Cedric Hermans
Critical Reviews in Oncology/Hematology|February 23, 2016
Is the cardiovascular toxicity of NSAIDS and COX-2 selective inhibitors underestimated in patients with haemophilia?Ana Boban, Catherine Lambert, Cedric Hermans
Case Reports in Hematology|July 21, 2016
Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with RivaroxabanAna Boban, Catherine Lambert, Cedric Hermans
Thrombosis Research|August 2, 2018
Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformationsQuentin Binet, Catherine Lambert, Cedric Hermans
Blood Transfusion = Trasfusione Del Sangue|November 5, 2014
Participation of people with haemophilia in clinical trials of new treatments: an investigation of patients' motivations and existing barriersSéverine Henrard, Niko Speybroeck, Cedric Hermans
Pageof 23

Showing results (51-60 of 222) with videos related to

Sort By:
Pageof 23
Blood Advances|July 1, 2020
First report of emicizumab use in a female patient with severe hemophilia AGéraldine Verstraete, Catherine Lambert, Cedric Hermans
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 22, 2021
Recombinant FVIIa in elective non-orthopaedic surgery of adults with haemophilia and inhibitors: A systematic literature reviewGerard Dolan, Jan Astermark, Cedric Hermans
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 16, 2022
Emicizumab dose capping in obese patients with Haemophilia A: Early outcomes at a single centreEvelien Krumb, Catherine Lambert, Cedric Hermans
Thrombosis and Haemostasis|March 9, 2012
Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiencyCedric Hermans, Stéphane Eeckhoudt, Catherine Lambert
Haematologica|May 7, 2013
Impact of being underweight or overweight on factor VIII dosing in hemophilia A patientsSéverine Henrard, Niko Speybroeck, Cedric Hermans
Clinical Toxicology (Philadelphia, Pa.)|March 18, 2008
Kinetics and determinants of the changes of CC16, a lung secretory protein in a rat model of toxic lung injuryPhilippe Hantson, Alfred Bernard, Cedric Hermans
Critical Reviews in Oncology/Hematology|February 23, 2016
Is the cardiovascular toxicity of NSAIDS and COX-2 selective inhibitors underestimated in patients with haemophilia?Ana Boban, Catherine Lambert, Cedric Hermans
Case Reports in Hematology|July 21, 2016
Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with RivaroxabanAna Boban, Catherine Lambert, Cedric Hermans
Thrombosis Research|August 2, 2018
Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformationsQuentin Binet, Catherine Lambert, Cedric Hermans
Blood Transfusion = Trasfusione Del Sangue|November 5, 2014
Participation of people with haemophilia in clinical trials of new treatments: an investigation of patients' motivations and existing barriersSéverine Henrard, Niko Speybroeck, Cedric Hermans
Pageof 23